Cost-driven revolution in diabetes management ahead
This article was originally published in Clinica
Executive Summary
A needlestick-free treatment regime awaits sufferers of diabetes in the coming decade, says a new report from Theta Reports, part of PJB Publications (see p 26 of this issue), says. Advancing technology and cost-containment pressures will likely see the end of both hypodermic insulin injections and finger-prick glucose monitoring, predicts The Future of Diabetes Diagnostics: Monitoring & Management in 2010.